Browse Studies — Arctuva

Observational

Fit2ThriveMB: Optimization of a Physical Activity Promotion Intervention for Metastatic Breast Cancer Patients

The purpose of this study is to examine which of four components of a digital health intervention using an App and Fitbit meaningfully contribute to increased …

Metastatic Breast CancerMetastatic Breast Cancer (MBC)Metastatic Breastcancer

Estimated

~$10 – $6,250

Northwestern UniversityNCT07840599

Observational

Evaluating a Patient Navigation Program to Improve Therapy Management for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib

The goal of this study is to test a novel nurse-delivered patient navigation program for women with HER2+ metastatic breast cancer (mBC) receiving tucatinib, t…

HER2+ Metastatic Breast Cancer (MBC)

Estimated

~$10 – $6,250

Duke UniversityNCT06983691

Phase 2

A Phase II Study Evaluating the Efficacy and Safety of Romosozumab as a Bone-Modifying Agent in Patients With Metastatic Breast Cancer to Bones and Osteoporosis With High Fracture Risk (REMOLD-Breast)

The researchers are doing this study to see if romosozumab is effective at helping with bone formation in people with metastatic breast cancer (MBC) that has s…

Breast CancerMetastatic Breast Cancer (MBC)

Estimated

~$10 – $6,250

Memorial Sloan Kettering Cancer CenterNCT07776613

CTC-EXPRESS: A Prospective Observational Study for CTC Expression and cfDNA/RNA Assessment in Metastatic Breast Cancer

The purpose of this research is to learn if the CellSearch Circulating Tumor Cells (CTC) test can help doctors in making decisions about treatment and monitori…

Metastatic Breast Cancer (MBC)

Estimated

~$10 – $1,050

Menarini Silicon Biosystems, INCNCT06833853